当前位置：
X-MOL 学术
›
Expert Rev. Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Bimekizumab for the treatment of psoriatic arthritis
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-01-21 , DOI: 10.1080/1744666x.2023.2277266 Yoshiya Tanaka 1 , Stevan Shaw 2
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-01-21 , DOI: 10.1080/1744666x.2023.2277266 Yoshiya Tanaka 1 , Stevan Shaw 2
Affiliation
Interleukin (IL)-17A and IL-17F have overlapping roles in pro-inflammatory signaling and have been implicated in the pathogenesis of psoriatic disease. Bimekizumab is the first human monoclonal ant...
中文翻译：
Bimekizumab 用于治疗银屑病关节炎
白细胞介素 (IL)-17A 和 IL-17F 在促炎信号传导中具有重叠的作用，并且与银屑病的发病机制有关。 Bimekizumab 是第一个人类单克隆蚂蚁...
更新日期：2024-01-21
中文翻译：
Bimekizumab 用于治疗银屑病关节炎
白细胞介素 (IL)-17A 和 IL-17F 在促炎信号传导中具有重叠的作用，并且与银屑病的发病机制有关。 Bimekizumab 是第一个人类单克隆蚂蚁...
京公网安备 11010802027423号